Research Article
The Utility of Serial Allograft Biopsies during Delayed Graft Function in Renal Transplantation under Current Immunosuppressive Regimens
Table 1
Comparison of selected variables in the rejection and no-rejection groups.
| | Variable | Rejection group (; 3 with ≥Banff-1A, 1 with acute humoral, and 6 with Banff-borderline) | No-rejection group | value |
| | ATG/Basiliximab induction (%) | 50/50 | 81/19 | 0.044 | | Recipient age (years) | | | 0.050 | | PRA level pretransplant (%) | | | 0.021 | | Living/deceased donor recipients (%) | 20/80 | 5/95 | 0.010 | | Recipient race: African American/other (%) | 50/50 | 55/45 | 1.000 | | Number of donor recipient HLA A, B, and DR mismatches | | | 0.870 | | Absolute lymphocyte count/mm3 in the week preceding biopsy | | | 0.431 | | Trough tacrolimus level in the week preceding biopsy (ng/mL) | | | 0.562 |
|
|
